ArticleScientific reports2026
Isolation and characterization of lactic acid bacteria from Heteropneustes fossilis for probiotic applications in aquaculture.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluating the probiotic potential of Bacillus pumilus HFS2 isolated from the gut microbiota of Heteropneustes fossilis for aquaculture applications.Journal, genetic engineering & biotechnology · 2026Article
- Probiotic potential of autochthonous Enterobacter mori ASP8 and Bacillus stercoris ASP10 isolated from gut microbiota of healthy stinging catfish, Heteropneustes fossilis (Bloch).Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Potential Lactic Acid Bacteria Characterized From the Gastrointestinal Tract of Butter Catfish,International journal of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Probiotics, notably lactic acid bacteria (LAB), provide an alternative to chemical treatments and therapeutics by improving microbial balance and supporting overall health. This study aimed to investigate the probiotic potential of LAB from Heteropneustes fossilis as feed additives in aquaculture. The experiments were focused on morphological, physiological, and molecular characterization of LAB isolates from the intestines of H. fossilis. Four strains of LAB belonging to the Lactococcus genus were identified: L. lactis HFL8, L. garvieae HFL1, L. garvieae HFL7, and L. formosensis HFL6. Among these, L. lactis HFL8 emerged as a promising probiotic candidate due to its strong tolerance to diverse environmental and physiological conditions, including fluctuations in temperature, pH, and NaCl concentration, as well as exposure to gut bile. L. lactis HFL8 exhibited growth at temperatures up to 45 °C and survived at 4 °C without proliferation. The strain tolerated acidic conditions as low as pH 2.0 and withstood gut bile concentrations up to 7.5%. In safety tests, the isolate exhibited no hemolytic activity and showed susceptibility to several commonly used antibiotics, being sensitive to ampicillin, vancomycin, erythromycin, tetracycline, chloramphenicol, and ciprofloxacin, while exhibiting resistance only to cefotaxime, suggesting that this strain appears safe for the host organisms. In addition, L. lactis HFL8 demonstrated strong probiotic traits, including high hydrophobicity (69.38 ± 0.54% in xylene and 67.83 ± 1.29% in toluene), robust autoaggregation (67.20 ± 0.18%), and substantial coaggregation with Bacillus pumilus (54.51 ± 0.87%) and Staphylococcus petrasii (51.37 ± 1.19%). Furthermore, L. lactis HFL8 demonstrated strong in vitro inhibitory activity against the fish pathogens Lactococcus garvieae and Aeromonas hydrophila. Collectively, these results suggest that L. lactis HFL8, isolated from H. fossilis, emerges as a potential probiotic candidate for aquaculture applications. Therefore, L. lactis HFL8 holds potential for future incorporation into functional feed formulations to enhance fish health, disease resistance, and overall sustainability in aquaculture systems. Collectively, the use of LAB-based indigenous probiotics could contribute to reduce antibiotic dependence, strengthen biosecurity, and promote more sustainable growth across the aquaculture industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.